BCL2L1 and lymphoma: Overexpression of BCL-2 and associated anti-apoptotic proteins Bcl-xL, Mcl-1, and BCL-W occurs in substantial subsets of common cancer types that include pancreatic, ovarian, lymphoma, multiple myeloma, lung adenocarcinoma, prostate adenocarcinoma, etc [27,28].